Follow
Kelly Mercier
Kelly Mercier
Daiichi Sankyo, Duke University, Desmoid Tumor Research Foundation
Verified email at duke.edu
Title
Cited by
Cited by
Year
Comparison of protein active site structures for functional annotation of proteins and drug design
R Powers, JC Copeland, K Germer, KA Mercier, V Ramanathan, ...
Proteins: Structure, Function, and Bioinformatics 65 (1), 124-135, 2006
1252006
FAST-NMR: functional annotation screening technology using NMR spectroscopy
KA Mercier, M Baran, V Ramanathan, P Revesz, R Xiao, GT Montelione, ...
Journal of the American Chemical Society 128 (47), 15292-15299, 2006
522006
The application of FAST-NMR for the identification of novel drug discovery targets
R Powers, KA Mercier, JC Copeland
Drug Discovery Today 13 (3-4), 172-179, 2008
402008
Metabolomics reveals new mechanisms for pathogenesis in Barth syndrome and introduces novel roles for cardiolipin in cellular function
Y Sandlers, K Mercier, W Pathmasiri, J Carlson, S McRitchie, S Sumner, ...
PloS one 11 (3), e0151802, 2016
382016
Design and characterization of a functional library for NMR screening against novel protein targets
KA Mercier, K Germer, R Powers
Combinatorial Chemistry & High Throughput Screening 9 (7), 515-534, 2006
352006
Identification and Functional Characterization of a Novel Acetylcholine-Binding Protein from the Marine Annelid Capitella teleta
T McCormack, RM Petrovich, KA Mercier, EF DeRose, MJ Cuneo, ...
Biochemistry 49 (10), 2279-2287, 2010
322010
Determining the optimal size of small molecule mixtures for high throughput NMR screening
KA Mercier, R Powers
Journal of Biomolecular NMR 31, 243-258, 2005
322005
A metabolomics pilot study on desmoid tumors and novel drug candidates
KA Mercier, M Al-Jazrawe, R Poon, Z Acuff, B Alman
Scientific reports 8 (1), 584, 2018
302018
A multi-step NMR screen for the identification and evaluation of chemical leads for drug discovery
KA Mercier, MD Shortridge, R Powers
Combinatorial chemistry & high throughput screening 12 (3), 285-295, 2009
272009
Preterm neonatal urinary renal developmental and acute kidney injury metabolomic profiling: an exploratory study
K Mercier, S McRitchie, W Pathmasiri, A Novokhatny, R Koralkar, ...
Pediatric Nephrology 32, 151-161, 2017
212017
Structure and function of Pseudomonas aeruginosa protein PA1324 (21–170)
KA Mercier, JR Cort, MA Kennedy, EE Lockert, S Ni, MD Shortridge, ...
Protein Science 18 (3), 606-618, 2009
182009
Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay
J Remon, A Swalduz, D Planchard, S Ortiz-Cuaran, L Mezquita, L Lacroix, ...
PLoS One 15 (6), e0234302, 2020
172020
Solution structure and function of YndB, an AHSA1 protein from Bacillus subtilis
JL Stark, KA Mercier, GA Mueller, TB Acton, R Xiao, GT Montelione, ...
Proteins: Structure, Function, and Bioinformatics 78 (16), 3328-3340, 2010
172010
Metabolic profiling of a chronic kidney disease cohort reveals metabolic phenotype more likely to benefit from a probiotic
SJ Saggi, K Mercier, JR Gooding, E Friedman, U Vyas, N Ranganathan, ...
International journal of probiotics & prebiotics 12 (1), 43, 2017
132017
Microfluidics meets metabolomics to reveal the impact of Campylobacter jejuni infection on biochemical pathways
NP Mortensen, KA Mercier, S McRitchie, TB Cavallo, W Pathmasiri, ...
Biomedical microdevices 18, 1-11, 2016
132016
Effect of endotoxin and alum adjuvant vaccine on peanut allergy.
HF Johnson-Weaver, B.T., McRitchie, S., Mercier, K.A., Pathmasiri, W ...
J Allergy Clin Immunol., 2017
5*2017
1H, 13C, and 15N NMR assignments for the Bacillus subtilis yndB START domain
KA Mercier, GA Mueller, TB Acton, R Xiao, GT Montelione, R Powers
Biomolecular NMR assignments 3, 191-194, 2009
52009
A retrospective collection of diagnostic data from the desmoid tumor research foundation natural history study.
A Lucas, D Braggio, L Hernandez, K Mercier
Journal of Clinical Oncology 39 (15_suppl), e23549-e23549, 2021
32021
The initiation, design, and establishment of the desmoid tumor research foundation patient registry and natural history study
KA Mercier, DM Walsh
Rare Tumors 11, 2036361319880978, 2019
32019
Quality of life and tumor location in patients with desmoid tumors: Data from the desmoid tumor research foundation natural history study.
KA Mercier, L Hernandez, V Boulanger, A Seebald, S Rossov, K Milligan
Journal of Clinical Oncology 37 (15_suppl), e18291-e18291, 2019
22019
The system can't perform the operation now. Try again later.
Articles 1–20